Skip to main content

Table 4 Relevant pathogens identified from respiratory specimens

From: Impact of viral multiplex real-time PCR on management of respiratory tract infection: a retrospective cohort study

 

Total (n = 254)

Adults (n = 182)

Children (n = 72)

Bacteria, n (%)

66 (26.0)

54 (29.7)

12 (16.7)

  Haemophilus influenzae

12 (4.7)

11 (6.0)

1 (1.4)

  Klebsiella pneumoniae

8 (3.1)

6 (3.3)

2 (2.8)

  Staphylococcus aureus

4 (1.6)

1 (0.5)

3 (4.2)

  Escherichia coli

4 (1.6)

3 (1.6)

1 (1.4)

  Pseudomonas aeruginosa

4 (1.6)

4 (2.2)

0 (0.0)

  Streptococcus pneumoniae

3 (1.2)

2 (1.1)

1 (1.4)

  Streptococcus pyogenes

3 (1.2)

2 (1.1)

1 (1.4)

  Legionella pneumophila

3 (1.2)

3 (1.6)

0 (0.0)

  Mycobacterium tuberculosis

3 (1.2)

3 (1.6)

0 (0.0)

  Mycoplasma pneumoniae

1 (0.4)

0 (0.0)

1 (1.4)

 Other bacteria

21 (8.3)

19 (10.4)

2 (2.8)

Viruses, n (%)

119 (46.9)

54 (29.7)

65 (90.3)

 Rhinovirus A/B/C

33 (13.0)

16 (8.8)

17 (23.6)

 Influenza A virus

17 (6.7)

11 (6.0)

6 (8.3)

 Influenza B virus

4 (1.6)

0 (0.0)

4 (5.6)

 Adenovirus

14 (5.5)

4 (2.2)

10 (13.9)

 Bocavirus 1/2/3/4

9 (3.5)

0 (0.0)

9 (12.5)

 Respiratory syncytial virus A

8 (3.1)

4 (2.2)

4 (5.6)

 Respiratory syncytial virus B

6 (2.4)

5 (2.7)

1 (1.4)

 Parainfluenza virus 1

1 (0.4)

1 (0.5)

0 (0.0)

 Parainfluenza virus 2

1 (0.4)

0 (0.0)

1 (1.4)

 Parainfluenza virus 3

6 (2.4)

3 (1.6)

3 (4.2)

 Parainfluenza virus 4

5 (2.0)

2 (1.1)

3 (4.2)

 Human Metapneumovirus

5 (2.0)

2 (1.1)

3 (4.2)

 Enterovirus

3 (1.2)

0 (0.0)

3 (4.2)

 Coronavirus 229E

1 (0.4)

1 (0.5)

0 (0.0)

 Coronavirus NL63

2 (0.8)

1 (0.5)

1 (1.4)

 Coronavirus OC43

1 (0.4)

1 (0.5)

0 (0.0)

 Non respiratory viruses

3 (1.2)

3 (1.6)

0 (0.0)

Fungi, n (%)

10 (3.9)

9 (4.9)

1 (1.4)

 Pneumocystis jirovecii

6 (2.4)

6 (3.3)

0 (0.0)

 Other fungi

4 (1.6)

3 (1.6)

1 (1.4)

  1. Pathogens associated with mixed infections were counted individually